MBRX
MBRX
NASDAQ · Biotechnology

Moleculin Biotech Inc

$2.29
+0.05 (+2.23%)
Analyst Consensus
Strong Buy
9
Analysts
Moderate
Coverage
Buy 8 89%
Hold 1 11%
Sell 0 0%
Price Target
Analyst Price Target +1,010.5% upside
Low Target $14.54
Average Target $25.43
High Target $32.33
Current Price $2.29
Current
$2.29
Target
$25.43
$14.54 $25.43 avg $32.33
Scenario Analysis
Bear Case
$14.54
534.9%
Low target
Base Case
$25.43
+1,010.5%
Avg target
Bull Case
$32.33
+1,311.8%
High target
Risk/Reward
2.5x
Favorable
Price in Context
52-Week High
$28.75
-92.0% from high
52-Week Low
$1.79
+27.9% from low
Target vs 52W High
$25.43
-11.5% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +19.9%
AMGN
Amgen Inc
Hold 42 50% $190.87 -46.1%
GILD
Gilead Sciences Inc
Strong Buy 38 79% $362.68 +157.7%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -2.5%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -90.1%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -69.0%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 -12.3%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -29.5%